Last update: July 2, 2015
Minimal risk for breastfeeding and infant.
Excretion into breast milk is low. Serum levels of infants from treated nursing mothers have been shown to be very low.
Overall, short or long-term harmful effect has not been reported among breastfed infants. Neither negative effect on growth nor psychomotor development has been observed in breastfed infants.
Galactorrhea associated or not to hyperprolactinemia, may appear.
Although it is considered to be safe while breastfeeding, an alternative with lesser excretion into breast milk should be preferred.
Women who are on antidepressant treatment during pregnancy are in need of special and intensive support for breastfeeding because of a high risk of early weaning.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM